Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice

Increased levels of low-density lipoprotein cholesterol (LDL-C) are recognized as a primary risk factor for atherosclerotic cardiovascular disease, which remains the leading cause of death worldwide. Lowering LDL-C levels clearly reduces the risk of cardiovascular events, with benefits related to bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Maddalena, Fabris, Enrico, Barbisan, Davide, Massa, Laura, Sinagra, Gianfranco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924077/
https://www.ncbi.nlm.nih.gov/pubmed/34514551
http://dx.doi.org/10.1007/s40256-021-00497-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924077/
https://www.ncbi.nlm.nih.gov/pubmed/34514551
http://dx.doi.org/10.1007/s40256-021-00497-3

Ejemplares similares